Impact of GLO1 Knock Down on GLUT4 Trafficking and Glucose Uptake in L6 Myoblasts

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Engelbrecht, Britta ^a   Stratmann, Bernd ^a   Hess, Cornelius ^b   Tschoepe, Diethelm ^a   Gawlowski, Thomas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GLUCOSE TRANSPORTER 4; GLYOXALASE; GLYOXALASE 1; INSULIN RECEPTOR SUBSTRATE 1; METHYLGLYOXAL; PROTEIN AKT1; PROTEIN KINASE B BETA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DENSITY; CELL SURFACE; CONCENTRATION (PARAMETERS); DOWN REGULATION; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INTERNALIZATION; INTRACELLULAR SIGNALING; MYOBLAST; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

ANIMALS; APOPTOSIS; CELL LINE; DIABETES MELLITUS; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN RECEPTOR SUBSTRATE PROTEINS; LACTOYLGLUTATHIONE LYASE; MYOBLASTS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; PYRUVALDEHYDE; RATS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 84878131295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065195     Document Type: Article

References (57)

1. Han Y, Randell E, Vasdev S, Gill V, Gadag V, et al. (2007) Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes. Mol Cell Biochem 305: 123-131.
2. McLellan AC, Phillips SA, Thornalley PJ, (1992) The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal Biochem 206: 17-23.
3. Thornalley PJ, (2008) Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease. Drug Metabol Drug Interact 23: 125-150.
4. Brownlee M, (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46: 223-234.
5. Ogawa S, Nakayama K, Nakayama M, Mori T, Matsushima M, et al. (2010) Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure. Hypertension 56: 471-476.
6. Singh R, Barden A, Mori T, Beilin L, (2001) Advanced glycation end-products: a review. Diabetologia 44: 129-146.
7. Stratmann B, Gawlowski T, Tschoepe D, (2010) Diabetic cardiomyopathy--to take a long story serious. Herz 35: 161-168.
8. Chang T, Wu L, (2006) Methylglyoxal, oxidative stress, and hypertension. Can J Physiol Pharmacol 84: 1229-1238.
9. Desai K, Wu L, (2007) Methylglyoxal and advanced glycation endproducts: new therapeutic horizons? Recent Pat Cardiovasc Drug Discov 2: 89-99.
10. Kalapos MP, (1999) Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol Lett 110: 145-175.
11. Lyles GA, Chalmers J, (1992) The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem Pharmacol 43: 1409-1414.
12. Degenhardt TP, Thorpe SR, Baynes JW, (1998) Chemical modification of proteins by methylglyoxal. Cell Mol Biol (Noisy-le-grand) 44: 1139-1145.
13. Gawlowski T, Stratmann B, Stork I, Engelbrecht B, Brodehl A, et al. (2009) Heat shock protein 27 modification is increased in the human diabetic failing heart. Horm Metab Res 41: 594-599.
14. Brownlee M, Cerami A, Vlassara H, (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321.
15. Cooper ME, (2004) Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. Am J Hypertens 17: 31S-38S.
16. Mostafa AA, Randell EW, Vasdev SC, Gill VD, Han Y, et al. (2007) Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes. Mol Cell Biochem 302: 35-42.
17. Abordo EA, Minhas HS, Thornalley PJ, (1999) Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem Pharmacol 58: 641-648.
18. Santarius T, Bignell GR, Greenman CD, Widaa S, Chen L, et al. (2010) GLO1-A novel amplified gene in human cancer. Genes Chromosomes Cancer 49: 711-725.
19. Thornalley PJ, (1993) The glyoxalase system in health and disease. Mol Aspects Med 14: 287-371.
20. Thornalley PJ, (2003) Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 31: 1343-1348.
21. Kalapos MP, (2008) The tandem of free radicals and methylglyoxal. Chem Biol Interact 171: 251-271.
22. Higaki Y, Mikami T, Fujii N, Hirshman MF, Koyama K, et al. (2008) Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol 3-kinase-dependent pathway. Am J Physiol Endocrinol Metab 294: E889-897.
23. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, et al. (2001) Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276: 48662-48669.
24. Toyoda T, Hayashi T, Miyamoto L, Yonemitsu S, Nakano M, et al. (2004) Possible involvement of the alpha1 isoform of 5′AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab 287: E166-173.
25. Lee J, Pilch PF, (1994) The insulin receptor: structure, function, and signaling. Am J Physiol 266: C319-334.
26. White MF, Kahn CR, (1994) The insulin signaling system. J Biol Chem 269: 1-4.
27. Watson RT, Kanzaki M, Pessin JE, (2004) Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25: 177-204.
28. Zaid H, Antonescu CN, Randhawa VK, Klip A, (2008) Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem J 413: 201-215.
29. Foley K, Boguslavsky S, Klip A, (2011) Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry 50: 3048-3061.
30. Ishiki M, Klip A, (2005) Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 146: 5071-5078.
31. Watson RT, Pessin JE, (2007) GLUT4 translocation: the last 200 nanometers. Cell Signal 19: 2209-2217.
32. Bryant NJ, Govers R, James DE, (2002) Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3: 267-277.
33. Dugani CB, Klip A, (2005) Glucose transporter 4: cycling, compartments and controversies. EMBO Rep 6: 1137-1142.
34. Zierath JR, Krook A, Wallberg-Henriksson H, (2000) Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43: 821-835.
35. Alzaid AA, (1996) Insulin resistance in non-insulin-dependent diabetes mellitus. A review. Acta Diabetol 33: 87-99.
36. Permutt MA, Wasson J, Cox N, (2005) Genetic epidemiology of diabetes. J Clin Invest 115: 1431-1439.
37. Guo Q, Mori T, Jiang Y, Hu C, Osaki Y, et al. (2009) Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats. J Hypertens 27: 1664-1671.
38. Jia X, Wu L, (2007) Accumulation of endogenous methylglyoxal impaired insulin signaling in adipose tissue of fructose-fed rats. Mol Cell Biochem 306: 133-139.
39. Riboulet-Chavey A, Pierron A, Durand I, Murdaca J, Giudicelli J, et al. (2006) Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species. Diabetes 55: 1289-1299.
40. Lee JJ, Hsiao CC, Yang IH, Chou MH, Wu CL, et al. (2012) High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5. Mol Vis 18: 838-850.
41. Hess C, Stratmann B, Quester W, Tschoepe D, Madea B, et al. (2013) Clinical and forensic examinations of glycaemic marker methylglyoxal by means of high performance liquid chromatography-tandem mass spectrometry. Int J Legal Med 127: 385-393.
42. McLellan AC, Thornalley PJ, Benn J, Sonksen PH, (1994) Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond) 87: 21-29.
43. Randell EW, Vasdev S, Gill V, (2005) Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography. J Pharmacol Toxicol Methods 51: 153-157.
44. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, et al. (2003b) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375: 581-592.
45. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, et al. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. Embo J 15: 6541-6551.
46. Brazil DP, Yang ZZ, Hemmings BA, (2004) Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 29: 233-242.
47. Altomare DA, Guo K, Cheng JQ, Sonoda G, Walsh K, et al. (1995) Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene 11: 1055-1060.
48. Bae SS, Cho H, Mu J, Birnbaum MJ, (2003) Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 278: 49530-49536.
49. Gonzalez E, McGraw TE, (2009) Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling. Proc Natl Acad Sci U S A 106: 7004-7009.
50. Ng Y, Ramm G, Lopez JA, James DE, (2008) Rapid activation of Akt2 is sufficient to stimulate GLUT4 translocation in 3T3-L1 adipocytes. Cell Metab 7: 348-356.
51. Horie T, Ono K, Nagao K, Nishi H, Kinoshita M, et al. (2008) Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes. J Cell Physiol 215: 733-742.
52. Mazlan M, Mansor R, Ngah WZW, (2010) Hydrogen peroxide stimulates glucose uptake in myotube cells via the insulin signaling pathway. Sains Malaysiana 39: 315-320.
53. Liu BF, Miyata S, Hirota Y, Higo S, Miyazaki H, et al. (2003) Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Int 63: 947-957.
54. Thornalley PJ, (1996) Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy. Gen Pharmacol 27: 565-573.
55. Dhar A, Dhar I, Desai KM, Wu L, (2010) Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose. Br J Pharmacol 161: 1843-1856.
56. Thong FS, Dugani CB, Klip A, (2005) Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology (Bethesda) 20: 271-284.
57. Yoshida A, Wei D, Nomura W, Izawa S, Inoue Y (2012) Reduction of Glucose Uptake through Inhibition of Hexose Transporters and Enhancement of Their Endocytosis by Methylglyoxal in Saccharomyces cerevisiae. J Biol Chem.